WHSC1/NSD2 regulates immune infiltration in prostate cancer

BACKGROUND: Immunotherapy in prostate cancer (PCa) lags behind the progresses obtained in other cancer types partially because of its limited immune infiltration. Tumor-resident immune cells have been detected in the prostate, but the regulatory mechanisms that govern tumor infiltration are still po...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Immunother Cancer
Main Authors: Want, Muzamil Y, Tsuji, Takemasa, Singh, Prashant K, Thorne, James L, Matsuzaki, Junko, Karasik, Ellen, Gillard, Bryan, Cortes Gomez, Eduardo, Koya, Richard C., Lugade, Amit, Odunsi, Kunle, Battaglia, Sebastiano
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2021
Assuntos:
Clinical/Translational Cancer Immunotherapy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7887377/
https://ncbi.nlm.nih.gov/pubmed/33589522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001374
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares